TFAP2A ‐Induced Upregulation of LncRNA NUTM2A ‐ AS1 Promotes LUAD Progression Through a miR ‐409‐5p/ SLC35F2 Regulatory Axis
Journal of Cellular and Molecular Medicine · 2026-07 · 30 (13)
DOI: 10.1111/jcmm.71284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 10.07.2026. Verfasst von Weiqin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Transcription Factor AP-2, RNA, Long Noncoding, MicroRNAs, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Changning District Committee of Science and Technology.
Abstract (Originalsprache)
Long non‐coding RNAs (LncRNAs) play pivotal roles in lung adenocarcinoma (LUAD) progression. However, the upstream transcriptional regulation and downstream mechanisms of LncRNA NUTM2A‐AS1 in LUAD remain largely unexplored. The expression levels of NUTM2A‐AS1, TFAP2A, miR‐409‐5p and SLC35F2 in LUAD tissues and cell lines were analysed using public databases and qRT‐PCR. The biological functions of this axis in LUAD cells were evaluated through CCK‐8, Transwell and apoptosis assays. The molecular interactions among TFAP2A, NUTM2A‐AS1, miR‐409‐5p and SLC35F2 were validated via chromatin immunoprecipitation (ChIP), dual‐luciferase reporter and RNA immunoprecipitation (RIP) assays. Both NUTM2A‐AS1 and TFAP2A were significantly upregulated in LUAD and correlated with poor prognosis. Mechanistically, the transcription factor TFAP2A directly bound to the NUTM2A‐AS1 promoter to activate its transcription. Functionally, NUTM2A‐AS1 promoted LUAD cell proliferation, migration, invasion and epithelial‐mesenchymal transition (EMT), while suppressing apoptosis. Furthermore, NUTM2A‐AS1 may function as a competing endogenous RNA‐like regulator by interacting with miR‐409‐5p, thereby upregulating the expression of the solute carrier family member SLC35F2. Rescue assays demonstrated that SLC35F2 knockdown attenuated the oncogenic phenotypes induced by TFAP2A or NUTM2A‐AS1, while miR‐409‐5p restoration suppressed SLC35F2 expression and cell‐cycle progression. Our study supports a TFAP2A/NUTM2A‐AS1/miR‐409‐5p/SLC35F2 regulatory model that contributes to LUAD progression. These findings suggest that the TFAP2A/NUTM2A‐AS1/miR‐409‐5p/SLC35F2 axis contributes to LUAD progression and may provide potential biomarkers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Feng Hu
Förderung
- Shanghai Changning District Committee of Science and Technology
Zitieren
APA
Wang, W., Liu, Y., Chen, T., Zhang, J., & Hu, F. (2026). TFAP2A ‐Induced Upregulation of LncRNA NUTM2A ‐ AS1 Promotes LUAD Progression Through a miR ‐409‐5p/ SLC35F2 Regulatory Axis. Journal of Cellular and Molecular Medicine, 30(13). https://doi.org/10.1111/jcmm.71284
Vancouver
Wang W, Liu Y, Chen T, Zhang J, Hu F. TFAP2A ‐Induced Upregulation of LncRNA NUTM2A ‐ AS1 Promotes LUAD Progression Through a miR ‐409‐5p/ SLC35F2 Regulatory Axis. Journal of Cellular and Molecular Medicine. 2026;30(13). doi:10.1111/jcmm.71284
BibTeX
@article{Wang2026,
author = {Wang, Weiqin and Liu, Yongfeng and Chen, Tiantian and Zhang, Jing and Hu, Feng},
title = {TFAP2A ‐Induced Upregulation of LncRNA NUTM2A ‐ AS1 Promotes LUAD Progression Through a miR ‐409‐5p/ SLC35F2 Regulatory Axis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {13},
doi = {10.1111/jcmm.71284}
}
EUVIMED